These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 8396615

  • 1. Effect of recombinant interferon gamma administration on lesional monocytes/macrophages in lepromatous leprosy patients.
    SivaSai KS, Prasad HK, Misra RS, Ramesh V, Wilfred D, Nath I.
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):259-69. PubMed ID: 8396615
    [Abstract] [Full Text] [Related]

  • 2. Effect of recombinant interferon-gamma on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy.
    Kaplan G, Nathan CF, Gandhi R, Horwitz MA, Levis WR, Cohn ZA.
    J Immunol; 1986 Aug 01; 137(3):983-7. PubMed ID: 3088117
    [Abstract] [Full Text] [Related]

  • 3. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF, Teles RM, Ribeiro-Carvalho MM, Teles RB, Santos IM, Ferreira H, Fulco TO, Nery JA, Sampaio EP, Sarno EN.
    Br J Dermatol; 2007 Aug 01; 157(2):273-83. PubMed ID: 17553031
    [Abstract] [Full Text] [Related]

  • 4. Effect of cutaneous cell-mediated immune response to rIFN gamma on Mycobacterium leprae viability in the lesions of lepromatous leprosy.
    Damasco MH, Sarno EN, Lobão AS, Alvarenga FB, Porto JA, Rosankaimer F, Kaplan G.
    Braz J Med Biol Res; 1992 Aug 01; 25(5):457-65. PubMed ID: 1342221
    [Abstract] [Full Text] [Related]

  • 5. Hydrogen peroxide and superoxide production by peripheral blood monocytes in leprosy.
    Sharp AK, Banerjee DK.
    Clin Exp Immunol; 1985 Apr 01; 60(1):203-6. PubMed ID: 2988833
    [Abstract] [Full Text] [Related]

  • 6. A comparison of monocyte oxidative responses in leprosy patients and healthy subjects as influenced by mycobacterial lipid pretreatment.
    Vachula M, Worobec S, Andersen BR.
    Int J Lepr Other Mycobact Dis; 1990 Sep 01; 58(3):534-9. PubMed ID: 2169513
    [Abstract] [Full Text] [Related]

  • 7. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.
    Nathan CF, Kaplan G, Levis WR, Nusrat A, Witmer MD, Sherwin SA, Job CK, Horowitz CR, Steinman RM, Cohn ZA.
    N Engl J Med; 1986 Jul 03; 315(1):6-15. PubMed ID: 3086725
    [Abstract] [Full Text] [Related]

  • 8. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP, Malta AM, Sarno EN, Kaplan G.
    Int J Lepr Other Mycobact Dis; 1996 Sep 03; 64(3):268-73. PubMed ID: 8862260
    [Abstract] [Full Text] [Related]

  • 9. Effect of IFN-gamma on the proliferation of Toxoplasma gondii in monocytes and monocyte-derived macrophages from AIDS patients.
    Delemarre FG, Stevenhagen A, Kroon FP, van Eer MY, Meenhorst PL, van Furth R.
    Immunology; 1994 Dec 03; 83(4):646-50. PubMed ID: 7875745
    [Abstract] [Full Text] [Related]

  • 10. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T, Kaur I, Kumar B, Radotra BD, Dogra S.
    Int J Lepr Other Mycobact Dis; 2005 Jun 03; 73(2):105-14. PubMed ID: 16830653
    [Abstract] [Full Text] [Related]

  • 11. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
    Iyer A, van Eijk M, Silva E, Hatta M, Faber W, Aerts JM, Das PK.
    Clin Immunol; 2009 Jun 03; 131(3):501-9. PubMed ID: 19307157
    [Abstract] [Full Text] [Related]

  • 12. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. II. Production of H2O2, O2- and interleukin-1.
    Sodhi A, Geetha B.
    Nat Immun Cell Growth Regul; 1989 Jun 03; 8(2):108-16. PubMed ID: 2548090
    [Abstract] [Full Text] [Related]

  • 13. Generation of superoxide anion by alveolar macrophages in sarcoidosis: evidence for the activation of the oxygen metabolism in patients with high-intensity alveolitis.
    Cassatella MA, Berton G, Agostini C, Zambello R, Trentin L, Cipriani A, Semenzato G.
    Immunology; 1989 Mar 03; 66(3):451-8. PubMed ID: 2539325
    [Abstract] [Full Text] [Related]

  • 14. Effect of glucocorticoids and interferon-gamma on the oxidative responses of monocytes from leprosy patients and normal donors.
    Vachula M, Holzer TJ, Nelson KE, Andersen BR.
    Int J Lepr Other Mycobact Dis; 1991 Mar 03; 59(1):41-8. PubMed ID: 1851508
    [Abstract] [Full Text] [Related]

  • 15. Cytokines in mycobacterial infections: in vitro and ex vivo studies.
    Flad HD, Gercken J, Hübner L, Schlüter C, Pryjma J, Ernst M.
    Arch Immunol Ther Exp (Warsz); 1995 Mar 03; 43(2):153-8. PubMed ID: 8744732
    [Abstract] [Full Text] [Related]

  • 16. Detection of transforming growth factor-beta 1 in dermal lesions of different clinical forms of leprosy.
    Goulart IM, Figueiredo F, Coimbra T, Foss NT.
    Am J Pathol; 1996 Mar 03; 148(3):911-7. PubMed ID: 8774145
    [Abstract] [Full Text] [Related]

  • 17. Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses.
    Hasan Z, Mahmood A, Zafar S, Khan AA, Hussain R.
    Int J Lepr Other Mycobact Dis; 2004 Mar 03; 72(1):35-44. PubMed ID: 15217317
    [Abstract] [Full Text] [Related]

  • 18. Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.
    Prasad CV, Kodliwadmath MV, Kodliwadmath GB.
    Lepr Rev; 2007 Dec 03; 78(4):391-7. PubMed ID: 18309714
    [Abstract] [Full Text] [Related]

  • 19. Use of reverse transcription polymerase chain reaction for the detection of Mycobacterium leprae in the slit-skin smears of leprosy patients.
    Jadhav RS, Kamble RR, Shinde VS, Edward S, Edward VK.
    Indian J Lepr; 2005 Dec 03; 77(2):116-27. PubMed ID: 16044809
    [Abstract] [Full Text] [Related]

  • 20. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
    de la Barrera S, Finiasz DM, Fink S, Valdez R, Bottasso O, Balina LM, Sasiain MC.
    Int J Lepr Other Mycobact Dis; 1997 Mar 03; 65(1):45-55. PubMed ID: 9207753
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.